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Identification of an unusual Brucella strain (BO2)
from a lung biopsy in a 52 year-old patient with
chronic destructive pneumonia
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Abstract
Background: Brucellosis is primarily a zoonotic disease caused by Brucella species. There are currently ten Brucella
spp. including the recently identified novel B. inopinata sp. isolated from a wound associated with a breast implant
infection. In this study we report on the identification of an unusual Brucella-like strain (BO2) isolated from a lung
biopsy in a 52-year-old patient in Australia with a clinical history of chronic destructive pneumonia.
Results: Standard biochemical profiles confirmed that the unusual strain was a member of the Brucella genus and
the full-length 16S rRNA gene sequence was 100% identical to the recently identified B. inopinata sp. nov. (type
strain BO1T). Additional sequence analysis of the recA, omp2a and 2b genes; and multiple locus sequence analysis
(MLSA) demonstrated that strain BO2 exhibited significant similarity to the B. inopinata sp. compared to any of the
other Brucella or Ochrobactrum species. Genotyping based on multiple-locus variable-number tandem repeat
analysis (MLVA) established that the BO2 and BO1Tstrains form a distinct phylogenetic cluster separate from the
other Brucella spp.
Conclusion: Based on these molecular and microbiological characterizations, we propose that the BO2 strain is a
novel lineage of the newly described B. inopinata species.
Background
Brucellosis is primarily a zoonotic disease, caused by
members of the genus Brucella, which currently consti-
tutes several species based on pathogenicity, host prefer-
ences and phenotypic characteristics: B. abortus (cattle),
B. canis (dogs), B. melitensis (goats), B. suis (pigs), B.
ovis (rams), B. neotomae (desert rats), B. ceti and B. pin-
nipedialis (marine mammals), and B. microti (common
vole) [1-6]. Recently, a novel species, Brucella inopinata,
associated with a human infection has been recognized
as the newest member of the genus Brucella [7,8]. In
early 1985, whole genome hybridization analysis studies
revealed a high degree of genetic homology among the
Brucella species, which led to the proposal that the
genus Brucella was a mono-specific species with B.
melitensis being the primary species and all others as
sub-species and biovars [9-11]. However, due to the lim-
ited acceptability of the one-species concept, the tradi-
tional classification of Brucella spp. based on phenotypic
characteristics has been re-instated by the Brucella Tax-
onomy Subcommittee in 2006 [3].
Brucella are facultative intracellular pathogens that
infect many organs and soft tissues, including mammary
glands. Infection frequently results in abortion, low milk
production and fetal death in animals [2,12-16]. Brucel-
losis in humans is mostly caused by B. abortus, B. meli-
tensis, B. suis, and sometimes B. canis [14,17-19], and is
commonly associated with the consumption of unpas-
teurized dairy products, meat from infected animals and
exposure to infected animal tissues or laboratory trans-
mission [1,2,20]. Human brucellosis is a chronic debili-
tating infection with a very broad clinical picture
potentially affecting any major organ, including the
lung, causing varying respiratory symptoms [20].
Respiratory infections in humans caused by Brucella
spp. is a rare manifestation with reports describing
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multifocal abscesses or nodules, hilar adenopathy and
hemorrhagic pleural effusion with resolution by antimi-
crobial therapy and lung decortications [21-26]. Most
pulmonary brucellosis cases were found in farmers
handling infected meat or travelers who consumed raw
infected animal meat or unpasteurized milk products
while visiting countries endemic for brucellosis [26,27].
We report the isolation and identification of an unu-
sual gram-negative, non-motile Brucella-like coccoid
bacillus (BO2) isolated from a lung biopsy in a 52-year-
old male in Australia with a history of chronic destruc-
tive pneumonia. The patient traveled worldwide but
denied any common risk factors associated with brucel-
losis. Both biochemical and molecular characteristics of
the BO2 strain have demonstrated unique similarity
with a recently described B. inopinata strain (BO1T)
associated with a breast implant wound of a 71-year-old
patient from Portland, Oregon with clinical signs of bru-
cellosis [7,8].
Results
Phenotypic characterization
BO2 cells grown on SBA or RBA at 35-37°C with or
without 5% CO2 for 24 to 48 h were circular, convex,
entire, smooth and opaque. The organisms were gram-
negative, generally stained uniformly; and appeared coc-
coid to short coryneform rods. Colonies of the BO2
strain ranged in size from punctuate to 1.5 mm in dia-
meter and they were non-motile, mucoid colonies on
MacConkey agar; positive for oxidase and catalase,
exhibited nitrate reduction with production of gas and
rapid urease production (< 5 min). Hydrogen sulfide
production by the BO2 strain was observed by the
development of a dark gray color on lead acetate paper
suspended above the heart infusion agar slant.
Subculture of individual colony types produced similar
profiles and no hemolytic reaction was observed on SBA
plates after overnight incubation at 37°C. The BO2 cells
grew in the presence of thionine (1:25,000, 1:50,000 and
1:100,000 dilutions) and basic fuchsin (1:50,000 and
1:100,000 dilutions) dyes within 24 to 48 h. Both the
acriflavin and gel formation tests were negative. How-
ever, lysis by Tbilisi phage specific for detection of Bru-
cella spp. in two routine test dilutions (1× and 4× RTD)
appeared incomplete [7,8,28] and agglutination of the
BO2 cells with either monospecific anti-M or anti-A
antisera were very weak.
Antimicrobial susceptibility test
The antimicrobial susceptibility profile of the BO2 strain
was compared with a set of 93 other Brucella spp.
strains (74 B. melitensis, 14 B. suis and 5 B. abortus)
along with BO1T based on CLSI interpretive require-
ments for Brucella spp. [8,29,30]. Both strains had very
similar MIC patterns to all Brucella reference strains
tested previously [8,30] (Table 1). BO1T and BO2 strains
grew well in cation-adjusted Mueller-Hinton broth
(CAMHB) after just 20 hours of incubation, unlike
other Brucella spp. (e.g., B. abortus, B. melitensis, and B.
suis) which do not routinely grow very well in CAMHB
and require 48 hours of incubation in Brucella broth for
MIC testing [30]. Our standard phenotypic characteriza-
tion, including the antimicrobial susceptibility profiles,
suggested that the BO2 strain more closely resembled
the BO1T strain of the B. inopinata sp. than the other
classical Brucella spp.
Molecular characterization
Detection of IS711 element by PCR
The Brucella specific insertion sequence (IS711) PCR
was performed amplifying an 842-bp repetitive element
using BO2 genomic DNA. The IS711 profile observed in
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Figure 1 IS711 profiles of PCR amplified products analyzed by gel electrophoresis on a 2% E-Gel displaying the following: molecular
weight marker (lane 1), no template control (lane 2), B. abortus ATCC 23448 (lane 3), B. melitensis 16 M (lane 4), B. suis ATCC 23444
(lane 5), B. ovis ATCC 25840 (lane 6), BO1T (lane 7), and BO2 (lane 8).
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strain BO2 was approximately the same size as that of
the BO1T strain and the classical Brucella spp. including
B. ovis (ATCC 25840) (Figure 1). The BO2 strain also
generated several large amplicons (>1000 bp) similar to
BO1T and other Brucella strains with low intensity as
reported earlier [8].
Real-Time PCR for BO1T/BO2
A TaqMan PCR assay targeting conserved regions of the
BO1T and Brucella spp.16S rRNA gene sequence was
designed for rapid differentiation of potential B. inopi-
nata-like strains from all other classical Brucella and
Ochrobactrum spp. This real-time PCR assay, using two
hybridization probes: BI-P specific for B. inopinata spp.
and BRU-P specific for Brucella/Ochrobactrum spp.,
gave average crossing threshold (Ct) values in the range
of 15 to 20 (strong positive). The BI-P probe demon-
strated perfect agreement for both BO1T and BO2
strains as did the BRU-P probe for all other Brucella or
Ochrobactrum spp. respectively. Both probes showed no
cross reactivity against the other non-Brucella strains
tested to date [31] demonstrating very high specificity of
the target sequences in the PCR assay. Both the BO1T/
BO2 and the Brucella/Ochrobactrum specific probes
were capable of optimal detection of template down to
10 fg/μl concentration of genomic DNA template (data
not shown).
16S rRNA gene sequence analysis
Rapid identification of the BO2 strain as B. inopinata-
like by the BO1 PCR assay led to sequence analysis of
the full-length 16S rRNA gene (1,412 bp) of the BO2
strain. Full sequence alignment with the 16S rRNA gene
sequences of BO1T, reference Orchrobactrum spp.
strains, and the Brucella spp. consensus sequence con-
firmed that the BO2 strain shared 100% 16S rRNA gene
sequence identity to that of BO1T and 99.6% identity
with other Brucella spp. (Table 2).
Omp2a/2b genes sequence analysis
We also analyzed two highly homologous outer mem-
brane porin genes (omp2a and omp2b) of the BO2 and
BO1Tstrains and compared their full-length sequences
with that of other Brucella species available in GenBank.
The phylogenetic relationships derived by neighbor-join-
ing clustering analysis of the BO2 omp2a (1093 bp) and
omp2b (~1212 bp) genes with the NCBI sequences of
other Brucella strains and the Ochrobactrum anthropi
LMG 3331 reference strain demonstrated considerable
intra- and inter-species variability (Figure 2). The BO2
omp2a and omp2b genes are 84.6% homologous to each
other. Neighbor-joining clustering analysis of both
omp2a and omp2b nucleotide sequences shows that
BO2 clusters closest to BO1T and an atypical B. suis 83-
210 strain [32]. The omp2a gene of BO2 is only 1.0%
divergent from that of BO1T. The omp2b gene is char-
acteristically more diverse within the Brucella spp. and
is also evident with the BO2 omp2b gene which was
95.3% and 94.1% identical to the BO1T and B. suis 83-
210 strains, respectively (Figure 2, Table 2). Clustering
analysis demonstrates that BO1T, BO2 and the B. suis
83-210 strains form consistent sub-groups based on
their omp2a and omp2b gene homology [32].
RecA gene sequence analysis
The recA gene (948 bp) of strain BO2 was compared to
those of BO1T, the classical Brucella spp.(n = 8) and
several representative Ochrobactrum spp. [31,33].
Within the genus Brucella, the recA gene is highly con-
served with 100% nucleotide sequence identity among
the different species. Interestingly, the BO2 recA nucleo-
tide sequence reveals 99.2% identity to the Brucella con-
sensus recA sequence due to 8 nucleotide substitutions.
However, the BO2 recA gene has a lower identity
(98.2%) when compared to the BO1T recA sequence dif-
fering by 17 nucleotides. Phylogenetic analysis of BO1T
and BO2 strains with other Brucella and Ochrobactrum
spp. shows that the Brucella spp. clade including BO2
and BO1T, are distantly similar to the Ochrobactrum
spp. with approximately 85% sequence identity (Figure
3).
Multiple Locus Sequence Analysis
Multiple locus sequence analysis (MLSA) of nine Bru-
cella spp. house-keeping genes has been used to
Table 1 MIC results for 5 antimicrobial agents tested against BO1T, BO2 strains and 93 Brucella strains
BO1T MIC (μg/ml) BO2 MIC (μg/ml) Brucella spp.a in Brucella
broth 48 h
CAMHBb Brucella Broth Brucella Broth CAMHB Brucella Broth Brucella Broth MIC Range MIC90
Antimicrobial agent 20 h 20 h 48 h 20 h 20 h 48 h (μg/ml) (μg/ml)
Doxycycline 0.25 0.25 0.5 0.25 0.25 0.5 0.06 - 1 0.25
Gentamicin 1 2 2 1 2 2 0.5 - 2 1
Streptomycin 4 4 4 2 4 4 1 - 8 4
Tetracycline 0.25 0.5 1 0.12 0.25 0.25 0.12 - 1 0.5
Trimethoprim-
sulfamethoxazole
0.5/9.5 0.25/4.75 0.5/9.50.25 0.5/9.5 0.25/4.75 0.5/9.5 0.12/2.38 - 0.5/9.5 0.5/9.5
a Ninety-three Brucella isolates (74 B. meli1tensis, 14 B. suis, and 5 B. abortus) were tested [30].
b CAMHB = cation-adjusted Mueller-Hinton broth.
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differentiate Brucella spp. into distinct sequence types
(ST). BO1T was determined to be 1.67% divergent from
ST1 and to possess novel alleles at all nine loci [8]. BO2
has shown similar divergence (1.5%) from ST1 by MLSA
also with novel alleles in all nine loci. Neighbor-joining
phylogenetic analysis clearly shows how divergent the
BO1T and BO2 species are from the classical Brucella
sequence types (Figure 4). Throughout the 4,396-bp
sequence examined, the BO1T and BO2 genomes have
32 common SNPs while there are 30 BO1T and 26 BO2
specific nucleotide changes that further characterize the
divergence of these two strains at these highly conserved
loci in the Brucella genus.
Multiple-Locus Variable-Number Tandem Repeat Analyses
Both BO2 and BO1T strains were also investigated by
multiple-locus variable-number tandem repeat (VNTR)
analysis (MLVA) using fifteen VNTR loci by capillary
electrophoresis. Results were compared with a panel of
well-characterized Brucella strains (n = 209) represent-
ing known species from our collection [31]. Our
MLVA-15 typing analysis of both BO2 and BO1T strains
demonstrated unique VNTR profiles in which both
strains have six Brucella-loci with the same alleles
(VNTR 2, -3, -14, -20, -21 and -25); and seven loci with
variable VNTR amplicons (VNTR1, -7, -27, -29, -30, -31
and -33). All VNTRs successfully amplified in both BO1
and BO2 with the exception of VNTR16 and -28 in
BO1T. MLVA-15 analysis revealed that both BO2 and
BO1T had distinct VNTR profiles in comparison to each
other and other Brucella strains (Figure 5).
Discussion
In this paper we present the identification of an atypical
Brucella-like strain (BO2) isolated from the lung biopsy
of a 52-year-old patient. As a young adult he lived in
Oregon on two occasions (1981 and 1985-1987), and
experienced an unexplained ‘liver failure’ and then
severe pneumonia (with pleurisy) from which he recov-
ered with multiple courses of antimicrobial therapy as
reported by the patient to his physicians in Australia.
This patient was originally misdiagnosed because of the
misidentification of the BO2 strain as O. anthropi on an
AP1 20NE system. It is a common practice for clinical
labs to attempt rapid identification of gram-negative coc-
cobacillus organisms like Brucella spp. from blood cul-
ture using automated systems. However, the Brucella
spp. are often misidentified due to their similar phenoty-
pic characteristics to closely related organisms such as
Ochrobactrum spp. [34,35]. Though the patient was
initially treated for both Ochrobactrum and Brucella
infections due to the difficulties in diagnosis, he recov-
ered with an extended course of combination oral anti-
microbial therapy.
This BO2 strain is phenotypically and molecularly
similar to the recently identified B. inopinata type strain
(BO1T) recovered from a patient from Oregon, which
was also originally misidentified as O. anthropi by the
API 20E and API 20NE [7,8]. Both these strains share
common colony morphology and biochemical character-
istics including rapid urease and positive H2S produc-
tion, inability or very weak agglutination with Brucella
specific antisera for the lipopolysaccharide-O-antigens
or acriflavin. Neither the BO1T or BO2 strains supports
gel formation or exhibits growth inhibition to the dye
media as shown by common members of the genus Bru-
cella. BO2 also exhibited incomplete lysis by Tbilisi
phage and had very similar antimicrobial susceptibility
profiles to BO1T in comparison to other Brucella refer-
ence strains.
Insertion sequence (IS) fingerprinting in the Brucella
species has shown that the genomic localization and
copy number of the IS711 insertion element (also called
IS6501) is species-specific and could have an association
with specific pathogenicity for a preferred host [36-38].
The presence of multiple copies of BO1T-like IS711
insertion sequences suggest not only that BO2 is a
member of the Brucella genus (Figure 1) but that the
BO2-IS711 amplification pattern specifically resembles
that of the newly described B. inopinata species [8].
Positive identification of the BO2 strain as a member of
B. inopinata by our real-time BO1 PCR assay was signif-
icant. Both BO1T and BO2 strains were the cause of dis-
tinct and unusual forms of human brucellosis. Atypical
clinical isolates of this nature can often be misdiagnosed
by automated systems as was the case with BO1T and
the BO2 strain described here [8,35]. The availability of
the real-time TaqMan assay served as a reliable first-line
tool for determining B. inopinata-like species.
These initial findings led to further characterization
and sequence-based typing which provided additional
supporting evidence that this new BO2 strain most
resembles the B. inopinata sp. within the Brucella
genus. Using broad-range eubacterial primers, Gee et.
al. effectively demonstrated the advantage of 16S rRNA
gene sequencing to identify Brucella isolates reporting
100% identity in all the strains examined [31]. Interest-
ingly, the full-length 16S rRNA gene sequence of BO2
Table 2 Comparative percent identity based on pair-wise
analysis of five genes of BO2 with BO1T and classical
Brucella spp. using MEGA4.
BO2 genes B. inopinata BO1T (%) Brucella spp. (%)
16S rRNA 100.0 99.6
RecA 98.2 99.2
MLSA 98.7 98.3-98.6
Omp2a 99.0 85.4-98.4
Omp2b 95.3 83.8-95.3
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Figure 2 Phylogenetic tree reconstructed with omp2a (1093 bp) and omp2b (~1211 bp) sequences using MEGA v.4.0 neighbor joining
analysis. The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. The
significance of each branch is indicated by a bootstrap percentage calculated from 1000 replicates.
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was 100% identical to that of BO1T and 99.6% identical
to the Brucella spp. consensus 16S rRNA gene
sequence. The high sequence identity of the BO2 16S
rRNA sequence to the recently described B. inopinata
sp. is remarkable and represents the first recognized
Brucella species to have a divergent 16S rRNA sequence
[8].
The recA gene has been investigated as an alternative
phylogenetic marker for several bacterial genera due to
its highly conserved nature and ubiquity in prokaryotes
[33,39,40]. Unlike the high sequence homology of the
recA gene within the Brucella genus [41], we identified
unique variability in the recA gene sequences of BO2
and BO1T. Sequence analysis revealed that the recA
nucleotide sequence of the BO2 strain shared greater
similarity with the Brucella spp. recA consensus
sequence than to BO1T. Both BO2 and BO1T recA
sequences are distanced by 8 and 11 unique SNPs,
respectively, from the Brucella spp. recA consensus
sequence, and share only one common transversion at
the 517 nucleotide position. Translation of the recA
gene sequences of BO1T, BO2 and the Brucella spp.
consensus sequence shows that all base pair changes
were synonymous substitutions having no effect on pro-
tein structure or function. The Brucella outer mem-
brane proteins have been studied extensively for their
function in virulence, pathogenicity, bacteriophage
reception, antigenic factors and antibacterial evasion
[42-45]. The genetic variability among the omp genes
within the Brucella spp. has proven effective at
Figure 3 Phylogenetic tree reconstructed with recA (948 bp) sequences using MEGA v.4.0 neighbor joining analysis. The bootstrap
consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. The significance of each branch
is indicated by a bootstrap percentage calculated from 1000 replicates.
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characterizing Brucella spp. and strain types and is often
used for higher resolution molecular typing [4,32,43,45].
The omp2a/2b genetic analysis we report here is very
interesting in that BO2 consistently associates with not
only BO1T but the atypical B. suis 83-210 strain that
was isolated from a rodent in Australia [32]; and thus
further investigation may be warranted into rodents as a
possible natural reservoir for these novel Brucella
species.
Investigation of the nine housekeeping genes by multi
locus sequencing analysis demonstrates that BO2 is
genetically distinct from BO1T yet exhibits remarkably
similar divergence (1.5%) from the classical Brucella
sequence types as shown in Figure 4. The relative simi-
larity of the nucleotide sequences of BO1T and BO2 by
MLSA demonstrates uniquely distant sequence types
within the currently characterized Brucella spp. and
should be considered as a new group of STs within the
Brucella genus. They also exhibit distinct allelic profiles
by MLVA although all alleles in both the BO1T and
BO2 allelic profiles have been observed in other Brucella
spp. Furthermore, the phylogenetic analysis shown in
Figure 5 demonstrates that these strains form a single
separate cluster from the classical Brucella spp. [8].
The molecular and microbiological characteristics pre-
sented here provide supporting evidence that strain BO2
is most closely associated with the BO1T strain and
should be considered as a novel lineage of B. inopinata
sp. Attempting to understand the evolutionary origin of
these two strains is somewhat confounded by the inter-
esting and disparate medical histories of the case patients
(who both happened to have lived in Portland, Oregon)
from whom these strains were isolated and suggests that
there are new and emerging Brucella strains capable of
causing unusual presentation of human brucellosis.
Conclusion
Phenotypic and genomic analysis of the unusual Bru-
cella strain (BO2) from a lung biopsy have established it
as a lineage of the recently identified novel B. inopinata
sp. type strain BO1T, which was isolated from a wound
associated with a breast implant. This is the first report
of a human brucellosis case associated with chronic
destructive pneumonia caused by an atypical Brucella
strain. An interesting finding from our molecular analy-
sis reveals that both strains BO1T and BO2 appeared to
be closely related to a less-characterized B. suis strain
83-210 (isolated from a rodent in Australia) by their
omp2a/2b genes, which may suggest a common ancestor
and may also provide insight into the ecological niche,
and host reservoir for these novel Brucella strains caus-
ing unusual human infections.
Figure 4 Unrooted phylogenetic reconstruction of the concatenated sequences of nine house-keeping genes (4,396 bp) using the
neighbor-joining approach. Represented are the 27 known Brucella sequence types along with BO1T and their relation to BO2.
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Methods
Patient
The patient was born in Malta in 1956 and immigrated
to Australia at age two, where he would continually
return and eventually settle throughout extensive world-
wide travel including the Western region of the United
States. Between 2003 and 2007, the patient was hospita-
lized multiple times in different hospitals in Australia
for abnormal liver function, community acquired pneu-
monia, anterior chest wall abscess and sinus infection.
In September 2007 a percutaneous lung biopsy was per-
formed and a gram-negative organism was isolated from
a broth culture of the fine needle aspirate of the
patient’s lung and identified as Ochrobactrum anthropi
on an API20NE system. The testing laboratory was
aware of the possibility of Brucella sp. being misidenti-
fied as Ochrobactrum anthropi [35] and the isolate was
referred for further testing. The patient was treated with
combination therapy of doxycycline and rifampicin for
twelve months and ciprofloxacin for three months (the
latter was ceased after molecular testing confirmed Bru-
cella species). The culture was initially tested according
to standard microbiological and molecular procedures
and then forwarded to the Centers for Disease Control
and Prevention (CDC), Atlanta, GA, for further charac-
terization. This gram-negative organism was designated
as BO2 and stored at -70°C in defibrinated rabbit blood
until further evaluation.
Phenotypic analysis
The BO2 strain was routinely maintained on Trypticase
soy agar with 5% defribinated sheep blood agar (SBA) or
rabbit blood agar (RBA) (BBL Microbiology Systems,
Cockeysville, MD). Phenotypic identification of the BO2
strain was performed according to the laboratory
Figure 5 Condensed unweighted pair group method analysis (UPGMA) dendogram of multiple-locus variable number tandem repeat
analysis (MLVA) genotypes of BO1T, BO2 strains along with 209 characterized Brucella strains.
Tiller et al. BMC Microbiology 2010, 10:23
http://www.biomedcentral.com/1471-2180/10/23
Page 8 of 11
techniques in brucellosis described by Alton et. al. in
the World Health Organization monogram [7,8,28].
Antimicrobial susceptibility analysis
The antimicrobial susceptibility testing of the BO2 strain
was performed by the broth microdilution method in
CAMHB and Brucella broth in accordance with the
Clinical and Laboratory Standards Institute (CLSI) pro-
tocol as described previously [8,29]
Molecular analysis
Detection of IS711
To detect the Brucella-specific insertion sequence IS711
element (842 bp) [37], cell lysate DNA templates from
strains BO2, BO1T, B. abortus (ATCC 23448), B. suis
1330 (ATCC 23444), B. ovis (ATCC 25840) and B. meli-
tensis 16 M (ATCC 23456) were amplified and the
amplicons were analyzed by 2% E-Gel agarose gel elec-
trophoresis as mentioned previously [8].
Real-Time PCR assay
A real-time TaqMan PCR assay was developed targeting
a four base nucleotide substitution within the 16S rRNA
gene sequence of BO1T (positions 145 to 148; GenBank
accession no. EU053207). We designed two PCR pri-
mers16SF (5’-CGGGCCGATCATTTGC-3’) and16SR
(5’-AACTCAGGGAAACTTGTGCTAATACC-3’) to
amplify a 72-bp region of the 16S rRNA Brucella con-
sensus sequence and two hybridization probes, BI-P (5’-
AAATCTTTCCCCTTTCGGGCAC-3’) and BRU-P (5’-
AAATCTTTCCCCCGAAGGGCAC-3’), targeting a 4-bp
polymorphic region within the 72-bp amplicon. Both
probes were synthesized with a 6-carboxyfluorescein
reporter molecule attached at the 5’ end and Black Hole
Quencher 1 on the 3’ end. Each final PCR reaction mix
contained 2 μl of DNA template and 18 μl of PCR mas-
ter mixture containing 1 × LightCycler Faststart DNA
Master HybProbe mix (Roche Applied Sciences, India-
napolis, IN), 4 mM MgCl2, 0.4 μM of each primer and
0.2 μM of probe. The LightCycler thermal cycling con-
ditions were 95°C for 8 min followed by 45 cycles of 95°
C for 5 sec and 60°C for 5 sec ending in a 45°C hold for
1 min 15 sec. A panel of 54 well characterized Brucella
strains and 28 near-neighbors, including 5 Ochrobac-
trum strains [31] were evaluated by the assay. Positive
results are expressed in log scale as crossing threshold
values (Ct) of fluorescence released above the no-tem-
plate control baseline of 0.01 following each amplifica-
tion as described by the manufacturer.
16S rRNA gene analysis
The full length amplicon of 16S rRNA gene was gener-
ated using the BO2 cell-lysate DNA and sequenced
using the BigDye terminator cycle 3.1 sequencing kit
(ABI, Foster City, CA) as described previously [31]. A
comparative full-length sequence analysis of BO2 was
performed with the consensus 16S rRNA gene sequence
of Brucella spp. [31], and the Ochrobactrum
intermedium type strain (GeneBank accession no.
AM114411T) along with that of the B. inopinata BO1T
strain (GeneBank accession no. EU053207) using the
GCG Wisconsin software package (version 10.2;
Accelrys, San Diego, CA) and MEGA 4.0 [31,46].
Omp2a/2b and recA genes analysis
The full-length outer membrane porin genes omp2a and
omp2b, and also the recA gene of BO2 were sequenced
[33,45], and compared with sequences of BO1T and
other Brucella and Ochrobactrum spp. available in Gen-
Bank. Contigs were assembled and edited before multi-
ple sequence alignments were constructed in the
DNASTAR Lasergene 8 genetic analysis software suite
(DNASTAR Inc., Madison, WI). Neighbor-joining con-
sensus trees inferred from 1000 bootstrap replicates
were constructed using MEGA version 4.0 [46].
MLSA typing
To assess the relation of BO2 with other classical Brucella
spp. and BO1T, the multi locus sequence analysis (MLSA)
primer sets were used to amplify and sequence nine dis-
crete house-keeping genes as described previously [47].
Multiple sequences were aligned and neighbor-joining
phylogenetic trees were constructed as described above.
Sequence identities
Similarity values reported throughout the text and in
Table 2 were calculated from estimates of evolutionary
divergence between the sequences represented in the cor-
responding dendograms. All results are based on the pair-
wise analysis of inclusive sequences using the Maximum
Composite Likelihood method in MEGA 4.0 [46]. All posi-
tions containing gaps and missing data were eliminated
from the dataset.
MLVA typing
Molecular typing of the BO2 strain based on multiple-
locus variable-number tandem repeat (VNTR) analysis
(MLVA) was investigated by examining fifteen Brucella
spp. VNTR genetic markers (MLVA-15) [48,49], and a
distance tree was generated in BioNumerics v.5.1
(Applied Maths, Saint-Martens-Latem, Belgium) by clus-
tering analysis using the unweighted-pair group method
with arithmetic averages (UPGMA) and saved in newick
format. Tree manipulations and labeling were done in
MEGA 4.0 [46].
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